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Repeated Chlamydia trachomatis infections after treatment
are common. One reason is reinfection from untreated
partners in ongoing sexual partnerships. Mathematical
models that are used to predict the impact of screening on
reducing chlamydia prevalence often do not incorporate re-
infection and might overestimate the expected impact. We
describe a pair compartmental model that explicitly in-
corporates sexual partnership duration and reinfection. The
pair model predicts a weaker impact of screening when
compared directly with a model that does not accommodate
partnerships. Effective management of sex partners to pre-
vent reinfection might need to be strengthened in chlamydia
control programs.
Repeated infections with Chlamydia trachomatis (chlamydia)
after treatment are common [1, 2]. These are a potential obstacle
for controlling chlamydia, the most common notifiable in-
fection in the United States [3]. Batteiger et al used genotyping
and sexual histories to show that a fraction of repeat infections
among young women were reinfections from an untreated sex
partner within ongoing partnerships [1]. Other reasons included
infections from subsequent partners, persistent infection,
and failure to receive treatment [1]. Screening to identify and
treat asymptomatic cases is the intervention most often
recommended to reduce chlamydia prevalence and the in-
cidence of female complications [3]; repeated episodes of pelvic
inflammatory disease increase the risk of infertility [4]. High
levels of successful notification of sex partners and adherence to
treatment and prevention advice might be an important com-
ponent of chlamydia control strategies. In practice the con-
tributions of screening and partner notification to chlamydia
control cannot be disentangled.
Mathematical modeling is a tool for understanding the
transmission and spread of infections in populations. Both
individual-based [5] and compartmental models [6–9] have
been used to predict the impact of chlamydia screening inter-
ventions. In published compartmental models, partnerships have
not been incorporated explicitly and contacts are assumed to be
instantaneous [6–9]. These models therefore cannot explore the
role of partner notification as part of the screening strategy [10].
It is often assumed that omitting this feature does not matter,
because adding partner notification would result in an even
greater decrease in predicted prevalence [8]. However, if contacts
are instantaneous, reinfection within partnerships cannot occur.
The objective of this study was to explore the specific role of
chlamydial reinfection in ongoing partnerships in an in-
tervention that includes both screening and partner notification.
To allow direct comparison with a model that assumes in-
stantaneous partnerships, we developed a pair compartmental
model, which explicitly incorporates ongoing partnerships. Both
models were calibrated to the same baseline prevalence by
changing the transmission parameter, so the number of new cases
per unit of time was the same in both. We then compared the
impact of different screening and partner notification strategies.
METHODS
Description of the Models
The pair model was based on work by Kretzschmar and Dietz
[11] to study human immunodeficiency virus infection in men
who have sex with men. We adapted the model for heterosexual
contacts among young adults and incorporated a susceptible-
infected-recovered-susceptible (SIRS) structure (Figure 1A;
Appendix). In the model, transmission can only occur in a pair
of a susceptible and an infected individual (SI). Every partner-
ship starts with an episode of unprotected sexual intercourse
with subsequent unprotected contacts once a week (/), con-
sistent with published data [12]. This allows the duration of
partnerships in the model to be compared with those in em-
pirical studies that define the start of partnerships with a sex act.
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The duration of the infectious period (1/e) of chlamydia is
assumed to be 1 year. This takes into account that most in-
fections are asymptomatic and persist for .1 year [13, 14] but
some infections are shorter because symptomatic individuals
visit health services and are treated. We assumed a short period
of immunity after clearance (1/c 5 3 months) [13].
Every individual can receive screening (at rate a per year)
using a test with perfect sensitivity. Everyone with a positive test
accepts treatment, which is always effective. After treatment no
immunity is assumed [6]. The current partner of an infected
individual can be notified with probability q, where the partner
always accepts treatment. Partner notification is defined as the
successful search and treatment of the current partner and ad-
herence to a period of abstinence until infection has cleared.
We assumed that individuals have on average 1.5 new part-
ners per year [8] and that 70% of persons are in a partnership at
any time, based on published data [12]. This corresponds to
a pair formation rate (q) of 5.0/year and an average duration of
a partnership (1/r) of 0.47 years. We assumed a baseline chla-
mydia prevalence of 3.5% (the average among 15–24-years-olds
in Regan et al [8]) and adjusted the transmission probability (b)
to achieve this, resulting in a transmission probability per sex act
of 0.10. We assumed all parameters to be the same for males and
females (a sensitivity analysis on this assumption was made). In
the model, with prevalence at 3.5%, the percentage of women
repeatedly infected (a subsequent infection from the same or
another partner) 12 months after treatment was 16.2%.
We compared the pair model with a standard SIRS model
with instantaneous partnerships; reinfection within the same
partnership cannot occur and partner notification cannot be
explored (Figure 1B; Appendix). The durations of immunity
and the infectious period are the same in both models. The
transmission parameter (k) is obtained by also assuming 3.5%
preintervention steady state prevalence and 1.5 new partners per
year, which gives a transmission probability per partnership of
0.70 [15]. In both models the number of new infections per unit
of time (incidence) is the same. The number of people screened
per year is therefore the same in both models.
Analyses
We implemented screening for 5 years. We estimated the impact
of screening and partner notification from the preintervention
steady state prevalence in the pair model and the impact of
screening alone in the standard model. We calculated the dif-
ference between the predicted relative reduction in chlamydia
prevalence in the standard model and in the pair model at dif-
ferent levels of partner notification. We then estimated the level
of successful partner notification that is necessary in a model
with reinfection to achieve the same reduction in prevalence as
in the model without reinfection; we call this the point of
equality. Finally, we examine the effect of changing the duration
of immunity after natural clearance on the point of equality for
a fixed screening rate of 0.2/year. A sensitivity analysis of other
parameter values was also conducted (Appendix).
RESULTS
For a given screening rate, the decline in chlamydia prevalence
after 5 years is more pronounced in a model with instantaneous
partnerships in which reinfection cannot occur (standard
model) compared with the pair model that allows for reinfection
(Figure 2A). Partner notification increases the impact of the
intervention in the pair model because reinfection of treated
cases from infected partners in ongoing partnerships is pre-
vented, but this does not necessarily result in a greater impact of
screening than the standard model (Figure 2A).
The biggest difference in predicted impact between the 2
models is observed for screening rates between 0.1 and 0.4 per
year (Figure 2B). As the screening rate increases, the impact of
partner notification becomes less apparent. With no partner
notification (Figure 2B), the peak difference in the impact of
screening between the models is 8.2% at a screening rate of 0.25/
year. This corresponds to a population where each individual is
screened on average every 4 years. With increasing partner no-
tification, the impact of screening in the pair model comes close
to estimates from the standard model; the point of equality
occurs when 30% of current partners are successfully notified
II 
SR 
RR 
SI 
IR 
SS 
2 q 
1-q 
A   Pair Model B   Standard Model
I S 
R 
  I
Figure 1. Schematic overview of the chlamydia infection process in
a pair model that allows for reinfection in ongoing partnerships (A) and in
a standard model in which partnerships are instantaneous and reinfection
is not incorporated (B). In the pair model, a compartment consists of a pair
of 2 individuals which can be susceptible (S), infected (I), or recovered (R).
The pair formation process is independent of the infection process and is
therefore not shown in this figure. Transmission can only occur in a pair
including a susceptible and an infected individual (SI) with rate b/ (b
denotes the transmission probability per sex act and / the frequency of
sex acts, indicated in red). After chlamydial infection, an individual can
clear the infection naturally (with rate e per year, indicated in black). After
natural clearance, an individual is immune for a duration of 1/c years
(indicated in green). An individual can also be screened and treated (with
rate a per year) and can notify his or her partner with probability q
(indicated in blue). The partner always accepts treatment. After treatment
no immunity is assumed. In the standard model, the transmission
parameter k is a combination of the number of new partners per year and
the transmission probability per partnership.
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(Figure 2B). At higher partner notification levels, the impact of
screening is greater in the pair model than in the standard
model.
We explored the way in which the duration of immunity
after natural clearance affects the level of partner notification
at the point of equality (Figure 2C). When no immunity is
assumed in either model, a lower level of partner notification
is needed to reach the point of equality. The longer the du-
ration of immunity after natural clearance, the more partner
notification is needed to counterbalance the effect of re-
infection after screening.
We performed a sensitivity analysis of the point of equality for
other parameters in all plausible ranges (Appendix). Under the
ranges investigated, the model with reinfection always estimates
a less pronounced impact of screening than the standard model,
and the level of partner notification at the point of equality can
differ between 4% and 39%. When only 1 sex is screened the
magnitude of the difference between the models is similar, with
the peak screening rate shifted toward higher levels and a slightly
lower point of equality. Increasing the duration of screening
from 5 to 20 years resulted in a peak difference between the 2
models shifted to lower screening rates and a slightly lower point
of equality.
DISCUSSION
This study shows that, when reinfection by the current partner
after screening and treatment for chlamydia is taken into ac-
count in a pair model, the impact of screening on reducing
chlamydia prevalence is less pronounced than in a standard
model that allows only for instantaneous partnerships and in
which reinfection cannot happen. Even when partner notifica-
tion is included in a screening strategy in the pair model, the
impact on chlamydia prevalence can be less than that of
screening alone in a standard model. This indicates that it is not
valid to state that the predictions from a standard model of
chlamydia transmission are conservative [8, 10]; in some cases
such estimates can even be optimistic. This study supports the
theoretical proposal that partnerships should be incorporated
explicitly in mathematical models that assume that partner
notification is part of a strategy for controlling chlamydia
transmission [10].
This modeling study is intended to be illustrative rather than
predictive so that we could focus specifically on the role of re-
infection. We therefore made several simplifying assumptions.
Age structure was not included. Homogeneous mixing is as-
sumed, but we hypothesize that if a certain fraction of the
population has higher partner change rates and shorter part-
nerships, these individuals would have a higher probability of
repeated infection, and this would make notification of current
partners less effective. We also assumed men and women to be
the same; shortening the duration of the infectious period in
men resulted in an even higher point of equality. We did not
consider persistent infection because we assumed 100% treat-
ment efficacy. The repeat infection rate in the pair model was,
however, consistent with published studies [2]. For all other
parameters, within the ranges studied, the pair model always
estimates a less pronounced impact of screening compared with
the standard model (Appendix).
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Figure 2. Impact of screening men and women for 5 consecutive years
on chlamydia prevalence. A, Chlamydia prevalence in a pair model that
allows for reinfection in the absence (gray line) or presence of partner
notification (PN) (gray dashed line) and in the standard model (black line).
B, Difference in the estimated relative impact of screening of the 2
models in the absence of PN (black line) and in the presence of different
levels of PN (gray lines; lighter gray indicates higher levels of PN). The
straight black line shows the point of equality, the level of PN needed in
the pair model that allows for reinfection to estimate the same impact of
screening as the standard model. C, Point of equality for different
assumptions of the duration of immunity after natural clearance of
chlamydia for a screening rate of 0.2/year. For all levels of immunity, the
transmission probability per sex act (pair model) and the transmission
parameter (standard model) is calibrated to a 3.5% baseline prevalence.
The scenario used in A and B is indicated with a black dot.
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There is ongoing discussion about the role of immunity in
chlamydial infections [6]. We show that when immunity after
natural clearance exists, more partner notification is needed to
counterbalance the effect of reinfection; to achieve the same
baseline steady state prevalence, the transmission probability per
sex act in a model with immunity must be higher than in
a model without immunity, if all other parameters are assumed
equal. The probability of reinfection after screening is therefore
higher in a model with immunity, and more partner notification
is needed to counterbalance this. If immunity also exists after
screening and treatment, less reinfection will occur after
screening and lower partner notification levels are needed.
The absolute difference in the impact of screening on chla-
mydia prevalence between the 2 models was modest. In a large
population, however, this can translate into a large number of
episodes of reinfection within ongoing partnerships. Excluding
reinfections from a standard model might therefore improve
cost-effectiveness in favor of screening, particularly because the
risk of infertility increases with each subsequent episode of
pelvic inflammatory disease [4].
Our results have implications for the design of chlamydia
control strategies. We found that, in a model with reinfection,
30% of current sex partners need to be notified to counter-
balance the effect of reinfection. Although this sounds modest, it
requires full compliance with identifying and informing a sex
partner, treatment to be given and taken, and abstinence from
sexual intercourse until infection has cleared. Continuing high
chlamydia prevalence, even after regular repeated screening,
early treatment, and partner notification efforts, suggests that
this is difficult to achieve in practice [1]. Additional empirical
studies should seek to improve partner notification effectiveness
in practice, and additional modeling efforts should focus on
understanding the most promising partner notification strate-
gies. Our study suggests that effective management of sex
partners to prevent reinfection might need to be strengthened in
chlamydia control programs.
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APPENDIX
Description of the Model
We have developed a pair model with a SIRS structure. The
model explicitly describes the formation of pairs (P) and the
dissolution of pairs into singles (X) [16]. The model stratifies
the population by sex with the labels f andm describing females
and males, respectively. The male and female populations are
assumed to be of equal size; thus,Nf 5 Nm. The infection states
of the model are susceptible (S), infected (I), and recovered (R).
In the notation of singles, the first subscript defines the sex of
the single, and the second subscript defines the infection state.
In the notation of pairs, the first subscript defines the state of
infection of the female and the second subscript defines the
state of infection of the male. Thus PSI is a pair with an
uninfected female and an infected male, while PIS is a pair with
an infected female and an uninfected male. The distinction
between PSI and PIS is only important when different screening
rates are assumed for females and males, or when there are sex
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differences in the behavioral or infection parameters. For the
modeling results and Figure 1 described in the main text, we
assume that all parameters are the same in both sexes. However,
we performed a sensitivity analyses in this appendix in which
we screen only 1 sex.
Every infected individual can be screened at a rate a per year
(with af being the screening rate for females and am that for
males). When an individual is screened, the partner can be
notified with a probability q. A person can clear the infection
naturally with rate e (with 1/ef being the duration of the
infectious period for females and 1/em that for males). After
natural clearance a period of immunity (1/c) is assumed.
Pairs are formed with a pair formation rate q per year and
separate with rate r per year. The separation rate can be
calculated as the average per capita number of new partners
per year divided by the percentage of people in a partnership.
The pair formation rate can be calculated as the average per
capita number of new partners per year divided by the
percentage of persons who are single. Transmission can
occur only in partnerships, with / being the number of sex
acts per week, and b being the transmission probability per
sex act. Every partnership starts with a single sexual contact
by assuming that, on formation of a partnership between
a susceptible and an infected individual, they become a pair
of infected individuals with probability b, and they remain
a pair of an infected and a susceptible individual with
probability 1 – b until the next sex act [16].
The SIRS pair model is described by the following set of
differential equations:
dXf ;S
dt 5rðPSS1PSI1PSRÞ2qXf ;S1af Xf ;I1cXf ;R
dXf ;I
dt 5rðPIS1PII1PIRÞ2qXf ;I2

ef1af

Xf ;I
dXf ;R
dt 5rðPRS1PRI1PRRÞ2qXf ;R1ef Xf ;I2cXf ;R
dXm;S
dt 5rðPSS1PIS1PRSÞ2qXm;S1amXm;I1cXm;R
dXm;I
dt 5rðPSI1PII1PRIÞ2qXm;I2ðem1amÞXm;I
dXm;R
dt 5rðPSR1PIR1PRRÞ2qXm;R1emXm;I2cXm;R
dPSS
dt 52q
Xf ;SXm;S
X 2rPSS1af PIS1amPSI1

af1am

qPII
1cðPSR1PRSÞ
dPSI
dt 52ð12bÞq
Xf ;SXm;I
X 2ðr1/bÞPSI2ðem1amÞPSI
1af ð12qÞPII1cPRI
dPSR
dt 52q
Xf ;SXm;R
X 2rPSR1emPSI1cðPRR2PSRÞ1af PIR
dPIS
dt 52ð12bÞq
Xf ;IXm;S
X 2ðr1/bÞPIS2

ef1af

PIS1cPIR
1amð12qÞPII
dPII
dt 52q
Xf ;IXm;I
X 12bq
Xf ;SXm;I
X 12bq
Xf ;IXm;S
X 1/bPSI1/bPIS
2

r1am1af1ef1em

PII
dPIR
dt 52q
Xf ;IXm;R
X 2rPIR1emPII2

ef1c1af

PIR
dPRS
dt 52q
Xf ;RXm;S
X 2rPRS1ef PIS2cðPRS2PRRÞ1amPRI
dPRI
dt 52q
Xf ;RXm;I
X 2ðr1em1c1amÞPRI1ef PII
dPRR
dt 52q
Xf ;RXm;R
X 2rPRR1emPRI1ef PIR22cPRR
The number of singles is given as X 5 Xf 1 Xm 5
Xf,S 1 Xf,I 1 Xf,R 1 Xm,S 1 Xm,I 1 Xm,R, and the total
population size can be expressed as N 5 Xf 1 Xm 1
2(PSS 1 PSI 1 PSR 1 PIS 1 PII 1 PIR 1 PRS 1 PRI 1 PRR).
The differential equations of the standard SIRS is described by
the following set of differential equations:
dSf
dt52kSf
Im
Nm
1af If1cRf
dSm
dt 52kSm
If
Nf
1amIm1cRm
dIf
dt5kSf
Im
Nm
2

af1ef

If
dIm
dt5kSm
If
Nf
2ðam1emÞIm
dRf
dt 5ef If2cRf
dRm
dt 5emIm2cRm
The transmission parameter (k) is a combination of the
transmission probability per partnership times the number of
new partners per year. The transmission parameter is
adjusted to obtain the same baseline prevalence as in the
pair model.
Sensitivity Analyses
In the main text we showed that in a model that allows
for reinfection, a substantial amount of successful partner
notification is needed to estimate the same impact of screening
as in a standard model that does not allow for reinfection
(point of equality). In the sensitivity analyses, we explore the
point of equality for all parameters used in all plausible
parameter ranges. Because the point of equality is hardly
affected by the screening rate (Figure 2B), the sensitivity
analyses is performed for a screening rate of 0.2/year.
For all parameters ranges examined, we adjust the
transmission parameter (b and k) to obtain a baseline
steady-state preintervention prevalence of 3.5%. We only
explored the parameter ranges for which we could obtain
a transmission probability b between 0 and 1.
In the main text it is shown that when no immunity is
assumed in the model, the point of equality is at its lowest
(Figure 2C). Therefore, and for simplicity, some parts of the
analyses are done using a model without immunity after
natural clearance (SIS model). Figures showing the results of
the sensitivity analyses are available from the authors on
request.
Duration of Infectious Period. If the duration of the infectious
period is varied between 0.5 and 2 years in a SIS model, the level
of partner notification at the point of equality decreases
from 32.4% to 17.3%. Thus, with increasing duration of
the infectious period, less partner notification is needed to
counterbalance the effect of reinfection. This is because
increasing the infectious period results in a lower transmission
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rate per sex act, which results in lower reinfection rates.
Therefore, less partner notification is needed to reach the point
of equality.
We also explored a scenario in which men have a shorter
infectious period than women. Shortening the duration of the
infectious period in men to half a year and keeping the
infectious period of women 1 year resulted in a higher level of
partner notification at the point of equality (37.0%).
Behavioral Parameters. We explored the effect of changing
both the percentage of people in a partnership from 10% to
90% and the new number of partnerships per year from 1
partner up to 4 partners per year at steady state in a SIS model.
Within the ranges explored, the level of partner notification at
point of equality varies between 4.3% and 39.3%. The number
of new partners per year influences the estimates more than the
percentage of people in a partnership. A higher number of new
partnerships per year will automatically result in shorter
partnership durations. As a consequence, both models predict
almost the same impact of screening, and little partner
notification is needed to reach the point of equality. When
the new number of partners per year is low, and the percentage
of people in a partnership increases, the duration of the
partnerships will automatically increase, and the differences
between both models become more apparent. As a
consequence, more partner notification is needed to estimate
the same impact of screening in the pair model that allows for
reinfection compared with a standard model.
Transmission Parameters. In all analyses so far, we kept the
baseline preintervention steady-state prevalence at 3.5%.
Therefore, we also explored the effect of a different baseline
prevalence on the point of equality in a SIS model. For every value
of the baseline prevalence studied (0.5%–15%), we adjusted the
transmission parameter b and k. In the pair model, this can also
be seen as keeping b constant but changing the frequency of sex
acts between once every 7.3 and 0.6 days. For a baseline prevalence
of 0.5%, the level of partner notification at the point of equality is
30.3%, and this steadily decreases to a level of 9.1% when the
baseline prevalence is increased to 15%. With increasing baseline
prevalence, it becomes more likely that both partners are infected,
and hence partner notification becomes more efficient. Therefore,
less partner notification is needed to achieve the same impact of
screening without reinfection.
Screening. We also explored the results of screening only 1
sex for 5 consecutive years. In general, when only 1 sex is
screened, the impact of screening is less compared with when
both sexes are screened. The magnitude of the difference in the
predicted impact of screening between the model that assumes
instantaneous partnership and the pair model is more or less
similar as when both sexes are screened (Figure 2B). However,
the peak difference between the models is shifted toward higher
screening strategies. The partner notification at point of
equality is slightly lower (26.5%) than when both sexes are
screened.
In the main text, screening is implemented for 5 consecutive
years. Increasing the duration of screening from 5 to 20 years
resulted in a peak difference between the 2 models shifted
toward lower screening rates and a slightly lower partner
notification level at the point of equality (23.9%).
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